Streptococcal erythrogenic toxins induce neopterin formation in human peripheral blood mononuclear cells but not in the human myelomonocytoma cell line THP-1

Immunobiology

Volumn 195, Issue 3, 1996, Pages 314-322

  Murr, Christian ^a   Baier Bitterlich, Gabriele ^a   Fuchs, Dietmar ^a   Gerlach, Dieter ^b   Werner Felmayer, Gabriele ^a   Dierich, Manfred P ^a   Wachter, Helmut ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; GAMMA INTERFERON; MITOGENIC AGENT; NEOPTERIN;

ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; MYELOMONOCYTIC LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS;

EID: 0029791073     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(96)80048-9     Document Type: Article

References (31)

1. STEVENS, D. L., M. H. TANNER, J. WINSHIP, R. SWARTS, K. M. RIES, P. M. SCHLIEVERT, and E. KAPLAN. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321: 1.
2. NOWAK, R. 1994. Flesh-eating bacteria: not new, but still worrisome. Science 264: 1665.
3. JOHNSON, H. M., J. K. RUSSELL, and C. H. PONTZER. 1992. Superantigens in human disease. Sci. Am. 266: 42.
4. KÖHLER, W. 1992. Epidemiologie und Pathogenese von Streptokokkeninfektionen. Immun. Infekt. 20: 92.
5. ABE, J., J. FORRESTER, T. NAKAHARA, J. A. LAFFERTY, B. L. KOTZIN, and D. Y. M. LEUNG. 1991. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J. Immunol. 146: 3747.
6. MÜLLER-ALOUF, H., J. E. ALOUF, D. GERLACH, J.-H. OZEGOWSKI, C. FITTING, and J.-M. CAVAILLON. 1994. Comparative study of cytokine release by human peripheral blood mononuclear cells with Streptococcus pyogenes superantigenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect. Immun. 62: 4915.
7. BITTERLICH, G., G. SZABO, E. R. WERNER, C. LARCHER, D. FUCHS, A. HAUSEN, G. REIBNEGGER, T. F. SCHULZ, J. TROPPMAIR, H. WACHTER, and M. P. DIERICH. 1988. Selective induction of mononuclear phagocytes to produce neopterin by interferons. Immunobiol. 176: 228.
8. HUBER, C., J. R. BATCHELOR, D. FUCHS, A. HAUSEN, A. LANG, D. NIEDERWIESER, G. REIBNEGGER, P. SWETLY, J. TROPPMAIR, and H. WACHTER. 1984. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J. Exp. Med. 160: 310.
9. WERNER, E. R., G. WERNER-FELMAYER, D. FUCHS, A. HAUSEN, G. REIBNEGGER, J. J. YIM, W. PFLEIDERER, and H. WACHTER. 1990. Tetrahydrobiopterin biosynthetic activities in human macrophages, fibroblasts, THP-1, and T 24 cells. J. Biol. Chem. 265: 3189.
10. WACHTER, H., D. FUCHS, A. HAUSEN, G. REIBNEGGER, and E. R. WERNER. 1989. Neopterin as a marker for activation of cellular immunity: immunologic basic and clinical application. Adv. Clin. Chem. 27: 81.
11. SAMSONOV, M. Y., G. P. TILZ, O. EGOROVA, G. REIBNEGGER, R. M. BALABANOVA, E. L. NASSONOV, V. A. NASSONOVA, H. WACHTER, and D. FUCHS. 1995. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 4: 29.
12. WEISS, G., P. KRONBERGER, F. CONRAD, E. BODNER, H. WACHTER, and G. REIBNEGGER. 1993. Neopterin and prognosis in patients with adenocarcinoma of the colon. Cancer Res. 53: 260.
13. FUCHS, D., A. HAUSEN, G. REIBNEGGER, E. R. WERNER, M. P. DIERICH, and H. WACHTER. 1988. Neopterin as a marker for activated cell-mediated immunity: application in HIV infection. Immunol. Today 9: 150.
14. FAHEY, J. L., J. M. G. TAYLOR, R. DETELS, B. HOFMANN, R. MELMED, P. NISHANIAN, and J. V. GIORGI. 1990. The prognostic value of cellular and prognostic markers in infections with human immunodeficiency virus type I infection. N. Engl. J. Med. 322: 166.
15. REIBNEGGER, G., C. AICHBERGER, D. FUCHS, A. HAUSEN, M. SPIELBERGER, E. R. WERNER, R. MARGREITER, and H. WACHTER. 1991. Posttransplant neopterin excretion in renal allograft recipients: reliable diagnostic aid of acute rejection and predictive marker of longterm survival. Transplantation 52: 58.
16. WACHTER, H., D. FUCHS, A. HAUSEN, G. REIBNEGGER, G. WEISS, E. R. WERNER, and G. WERNER-FELMAYER. 1992. Neopterin. Biochemistry - Methods - Clinical Application. Berlin, New York: Walter de Gruyter.
17. FUCHS, D., M. MALKOVSKY, G. REIBNEGGER, E. R. WERNER, G. FORNI, and H. WACHTER. 1989. Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation. Immunol. Lett. 23: 103.
18. GERLACH, D., H. KNÖLL, W. KÖHLER, and J.-H. OZEGOWSKI. 1980. Isolation and characterization of erythrogenic toxins of Streptococcus pyogenes. 3. Comparative studies of type A erythrogenic toxins. Zbl. Bakt. Hyg. A 250: 277.
19. GERLACH, D., E. GÜNTHER, W. KÖHLER, S. VEPPERMANN, B. FLEISCHER, and K. H. SCHMIDT. 1995. Isolation and characterisation of a mitogen characteristic for A streptococci (Streptococcus pyogenes). Zbl. Bakt.; in press.
20. OZEGOWSKI, J.-H., L. WOLLWEBER, K. H. SCHMIDT, S. VEPPERMANN, W. REICHARDT, and W. KÖHLER. 1994. Streptococcal erythrogenic toxin type C is not a phosphorylated protein. Description of two different purification procedures and investigation of its phosphorylation state. FEMS Immunol. Med. Microbiol. 9: 65.
21. WERNER-FELMAYER, G., E. R. WERNER, D. FUCHS, A. HAUSEN, G. REIBNEGGER, and H. WACHTER. 1990. Neopterin formation and tryptophan degradation by a human myelomonocytic cell line (THP-1) upon cytokine treatment. Cancer Res. 50: 2863.
22. TREDE, S. N., E. CASTIGLI, R. S. GEHA, and T. CHATILA. 1993. Microbial superantigens induce NF-kB in the human monocytic cell line THP-1. J. Immunol. 150: 5604.
23. DIEZ-RUIZ, A., G. P. TILZ, R. ZANGERLE, G. BAIER-BITTERLICH, H. WACHTER, and D. FUCHS. 1995. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 54: 1.
24. TROPPMAIR, J., K. NACHBAUR, M. HEROLD, W. AULITZKY, H. TILG, G. GASTL, P. BIELING, B. KOTLAN, R. FLENER, B. MULL, W. O. AULITZKY, H. ROKOS, and C. HUBER. 1988. In vitro and in vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin. Exp. Immunol. 74: 392.
25. WERNER-FELMAYER G., E. R. WERNER, D. FUCHS, A. HAUSEN, G. REIBNEGGER, and H. WACHTER. 1989. Tumor necrosis factor and lipopolysaccharide enhance interferon-induced tryptophan degradation and pteridine synthesis in human cells. Biol. Chem. Hoppe-Seyler 370: 1063.
26. FUCHS, D., A. HAUSEN, M. KOFLER, H. KOSANOWSKI, G. REIBNEGGER, and H. WACHTER. 1984. Neopterin as an index of immune response in patients with tuberculosis. Lung 162: 337.
27. DIEZ-RUIZ, A., M. AL-AMRANI, G. WEISS, F. GUTIERREZ-GEA, H. WACHTER, and D. FUCHS. 1993. Increased interferon-γ and neopterin concentrations in patients with acute brucellosis. J. Infect. Dis. 167: 504.
28. NIEDERWIESER, A., P. JOLLER, A. SEGER, N. BLAU, A. PRADER, J. D. BETTEX, R. LÜTHY, B. HIRSCHEL, J. SCHAEDELIN, and U. VETTER. 1986. Neopterin in AIDS, other immunodeficiencies, and bacterial and viral infections. Klin. Wochenschr. 64: 333.
29. DENZ, H., D. FUCHS, A. HAUSEN, H. HUBER, D. NACHBAUR, G. REIBNEGGER, J. THALER, E. R. WERNER, and H. WACHTER. 1990. Value of urinary neopterin in the differential diagnosis of bacterial and viral infections. Klin. Wochenschr. 68: 218.
30. ROMAGNANI, S. 1991. Human Th 1 and Th 2: Doubt no more. Immunol. Today 12: 256.
31. WEISS, G., D. FUCHS, A. HAUSEN, G. REIBNEGGER, E. R. WERNER, G. WERNER-FELMAYER, E. SEMENITZ, M. P. DIERICH, and H. WACHTER. 1993. Neopterin modulates toxicity mediated by reactive oxygen and chlorine species. FEBS Lett. 321: 89.